Chip Catlin

Track

Insider profile

Currently holds positions in Provention Bio Inc and Corbus Pharmaceuticals Holdings Inc

Performance

Overall performance
3.6
Performance over holding periods
3.6
30 days 90 days 120 days
Average return 28% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
2 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Director Provention Bio Inc Sept. 5, 2018 -
Independent Director Corbus Pharmaceuticals Holdings Inc Aug. 1, 2014 -
Chief Financial Officer, Senior Vice President, Secretary Celldex Therapeutics Inc Jan. 1, 2001 - June 30, 2017
Chip Catlin's trades of Provention Bio Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
484.48
Quantity 40,152 -13.2%
Value US$3,276,250
Transaction date
Purchase
Price
315.63
Quantity 38,552 -5.7%
Value US$1,911,987
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2018-12-27 2018-12-26
B Purchase
40,152 -13.2%
484.48
US$3,276,250 		40,152 -13.2% 484.48 US$3,276,250
2018-12-27 2018-12-24
B Purchase
38,552 -5.7%
315.63
US$1,911,987 		38,552 -5.7% 315.63 US$1,911,987